E Fund Management Co., Ltd. Adma Biologics, Inc. Transaction History
E Fund Management Co., Ltd.
- $1.93 Billion
- Q3 2024
A detailed history of E Fund Management Co., Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 25,118 shares of ADMA stock, worth $490,805. This represents 0.03% of its overall portfolio holdings.
Number of Shares
25,118
Previous 16,998
47.77%
Holding current value
$490,805
Previous $190,000
164.21%
% of portfolio
0.03%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ADMA
# of Institutions
319Shares Held
185MCall Options Held
917KPut Options Held
91.6K-
Black Rock Inc. New York, NY18.6MShares$364 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.1MShares$354 Million0.01% of portfolio
-
State Street Corp Boston, MA13MShares$254 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.6MShares$247 Million0.05% of portfolio
-
Morgan Stanley New York, NY8.6MShares$168 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.84B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...